Loss of function mutations of the heparan sulfate proteoglycan gene glypican-3 (GPC3), causes an Xlinked disorder in humans known as Simpson Golabi Behmel syndrome (SGBS), a disorder associated with both pre- and postnatal overgrowth, a predisposition to certain childhood cancers, and a complex assortment of congenital defects. Mice bearing mutations in this same gene have similar features to humans with this disorder. Based primarily on in vitro studies, a number of biological activities have been ascribed to GPCS. The challenge has been to determine which of those functions are specifically associated with phenotypes seen in vivo, and whether these activities are unique to Gpc3. Addressing these issues are the long-term objectives of this proposal. While characterizing the development of Gpc3 deficient mice, we identified a previously unrecognized role for Gpc3 in the development of osteoclasts. In further characterization of these animals we have found that this phenotype arises due to an even broader role for Gpc3 in hematopoietic development. Specifically, loss of Gpc3 is associated with a defect along the common lineage leading to the differentiation of bone marrow precursors of the PMN, monocyte/macrophage, as well as the osteoclast cell lineages in vivo. Other cell types of the myeloid and lymphoid cell lineages are unaffected. This implies a unique role for Gpc3 in specific committed progenitor cells and is consistent with our preliminary findings that Gpc3 expression is highly restricted to rare progenitor cells of the hematopoietic lineage. We have further established that embryonic stem cells terminally differentiate along this lineage in a Gpc3-dependent fashion in vitro. This is the first in vivo demonstration of a functional requirement for any specific heparin sulfate proteoglycan in this particular aspect of hematopoiesis. Understanding this function has the potential to contribute to the broader understanding of the pathophysiology of diverse human diseases resulting in deficient production of these blood cells, hematological malignancies, as well as disorders involving bone homeostasis. Our short-term objectives are to pinpoint the biological mechanisms underlying the effect of Gpc3 loss of function on hematopoietic differentiation, and to use the in vitro hematopoietic differentiation of ES cells to establish the structural requirements and specificity of this function of GPC3.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK056063-08S1
Application #
7860956
Study Section
Special Emphasis Panel (ZRG1-PBC (01))
Program Officer
Malozowski, Saul N
Project Start
1999-07-01
Project End
2011-06-30
Budget Start
2009-07-15
Budget End
2011-06-30
Support Year
8
Fiscal Year
2009
Total Cost
$34,343
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ellies, Debra L; Economou, Androulla; Viviano, Beth et al. (2014) Wise regulates bone deposition through genetic interactions with Lrp5. PLoS One 9:e96257
Ng, Ann; Wong, Michelle; Viviano, Beth et al. (2009) Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development. Dev Biol 335:208-15
Thach, B T; Kenney-Hunt, J P; Simon, T C et al. (2009) Sex-specific quantitative trait loci linked to autoresuscitation failure in SWR/J mice. Heredity (Edinb) 103:469-75
Vachharajani, Akshaya; Bethin, Kathleen; Mouillet, Jean-Francois et al. (2006) The rare occurrence of absent adrenals in a term infant: a case report and review of the literature. Am J Perinatol 23:111-4
Ellies, Debra L; Viviano, Beth; McCarthy, John et al. (2006) Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 21:1738-49
Viviano, Beth L; Silverstein, Laura; Pflederer, Camila et al. (2005) Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification. Dev Biol 282:152-62
Vachharajani, Akshaya; Saunders, Scott (2005) Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in children. Biochem Biophys Res Commun 334:376-9
Viviano, Beth L; Paine-Saunders, Stephenie; Gasiunas, Nijole et al. (2004) Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem 279:5604-11
Paine-Saunders, Stephenie; Viviano, Beth L; Economides, Aris N et al. (2002) Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277:2089-96
DeBaun, M R; Ess, J; Saunders, S (2001) Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition. Mol Genet Metab 72:279-86

Showing the most recent 10 out of 11 publications